Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Depreciation & Amortization (CF): 2023-2025

Historic Depreciation & Amortization (CF) for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $46,000.

  • Upstream Bio's Depreciation & Amortization (CF) rose 228.57% to $46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $180,000, marking a year-over-year increase of 233.33%. This contributed to the annual value of $89,000 for FY2024, which is 48.33% up from last year.
  • Latest data reveals that Upstream Bio reported Depreciation & Amortization (CF) of $46,000 as of Q3 2025, which was up 9.52% from $42,000 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Depreciation & Amortization (CF) ranged from a high of $49,000 in Q4 2024 and a low of $13,000 during Q1 2024.
  • Over the past 3 years, Upstream Bio's median Depreciation & Amortization (CF) value was $28,000 (recorded in 2023), while the average stood at $29,250.
  • Data for Upstream Bio's Depreciation & Amortization (CF) shows a peak YoY soared of 250.00% (in 2024) over the last 5 years.
  • Over the past 3 years, Upstream Bio's Depreciation & Amortization (CF) (Quarterly) stood at $14,000 in 2023, then skyrocketed by 250.00% to $49,000 in 2024, then surged by 228.57% to $46,000 in 2025.
  • Its last three reported values are $46,000 in Q3 2025, $42,000 for Q2 2025, and $43,000 during Q1 2025.